1. Home
  2. CRESY vs AVXL Comparison

CRESY vs AVXL Comparison

Compare CRESY & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRESY
  • AVXL
  • Stock Information
  • Founded
  • CRESY 1936
  • AVXL 2004
  • Country
  • CRESY Argentina
  • AVXL United States
  • Employees
  • CRESY N/A
  • AVXL N/A
  • Industry
  • CRESY Real Estate
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CRESY Finance
  • AVXL Health Care
  • Exchange
  • CRESY Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • CRESY 749.3M
  • AVXL 710.3M
  • IPO Year
  • CRESY 1997
  • AVXL N/A
  • Fundamental
  • Price
  • CRESY $11.21
  • AVXL $8.27
  • Analyst Decision
  • CRESY
  • AVXL Strong Buy
  • Analyst Count
  • CRESY 0
  • AVXL 2
  • Target Price
  • CRESY N/A
  • AVXL $44.00
  • AVG Volume (30 Days)
  • CRESY 193.1K
  • AVXL 969.1K
  • Earning Date
  • CRESY 05-09-2025
  • AVXL 05-13-2025
  • Dividend Yield
  • CRESY 13.74%
  • AVXL N/A
  • EPS Growth
  • CRESY N/A
  • AVXL N/A
  • EPS
  • CRESY 0.09
  • AVXL N/A
  • Revenue
  • CRESY $648,198,954.00
  • AVXL N/A
  • Revenue This Year
  • CRESY N/A
  • AVXL N/A
  • Revenue Next Year
  • CRESY N/A
  • AVXL N/A
  • P/E Ratio
  • CRESY $11.20
  • AVXL N/A
  • Revenue Growth
  • CRESY N/A
  • AVXL N/A
  • 52 Week Low
  • CRESY $6.56
  • AVXL $3.51
  • 52 Week High
  • CRESY $14.23
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • CRESY 42.19
  • AVXL 53.19
  • Support Level
  • CRESY $11.85
  • AVXL $7.31
  • Resistance Level
  • CRESY $12.38
  • AVXL $7.90
  • Average True Range (ATR)
  • CRESY 0.55
  • AVXL 0.41
  • MACD
  • CRESY -0.10
  • AVXL 0.07
  • Stochastic Oscillator
  • CRESY 10.83
  • AVXL 85.38

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is engaged in agricultural business and urban properties and investment business. Under its agricultural business the company produces oilseed grains and cereals, sugar cane and meat. The Agricultural business of the company is further comprised of four reportable segments which are Agricultural production, Land transformation and Sales, Corporate and Other segments. The company participates in the real estate business in Argentina through its subsidiary IRSA. The real estate business is further comprised of five reportable segments, namely Shopping Malls, Offices, Sales and Developments, Hotels and others.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: